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Abstract
Background: The health-related quality of life (HRQoL) is currently weighted more heavily when evaluating health
status, particularly regarding medical treatments and interventions. However, it is rarely used by physicians to
compare responsiveness. Additionally, responsiveness estimates derived by the Harris Hip Score (HHS) and the
Short Form 36 (SF-36) before and after revision total hip arthroplasty (THA) have not been clinically compared. This
study compared responsiveness and minimal important differences (MID) between HHS and SF-36.
Methods: All revision THA patients completed the disease-specific HHS and the generic SF-36 before and 6
months after surgery. Scores using these instruments were interpreted by generalized estimating equation (GEE)
before and after revision THA. The bootstrap estimation and modified Jacknife test were used to derive 95%
confidence intervals for differences in the responsiveness estimates.
Results: Comparisons of effect size (ES), standardized response means (SRM), relative efficiency (RE) (>1) and MID
indicated that the responsiveness of HHS was superior to that of SF-36. The ES and SRM for pain and physical
functions in the HHS were significantly larger than those of the SF-36 (p < 0.001).
Conclusion: The data in this study indicated that clinicians and health researchers should weight disease-specific
measures more heavily than generic measures when evaluating treatment outcomes.
Background
Pain and physical function outcomes of total hip arthro-
plasty (THA) have been well documented during the
past twenty years [1,2]. This intervention has proven
safe and effective for improving health-related quality of
life (HRQoL) [3].
Various HRQoL instruments have been used with
increasing frequency during the past decade [3]. Dis-
ease-specific measures are traditionally administered in
longitudinal studies to detect progressive changes in
health and quality of life after interventions and tend to
focus on physical function and pain. Conversely, generic
measures are designed to assess the effects of any dis-
ease or condition and have value for measuring health
status. The Harris Hip Score (HHS) is a commonly used
physician assessment of physical functioning and pain
relief on clinical sites [4]. The Medical Outcomes Study
Short Form-36 Health Survey (SF-36) is a self-
administered generic HRQoL instrument commonly
used to assess overall outcome [5].
Responsiveness is measured by comparing changes in
clinical endpoints and changes in instrument outcomes
over time in either observational or clinical trials [6,7].
Responsiveness is an important consideration when
selecting HRQoL measures for clinical trials or medical
interventions. Minimal important difference (MID) is
defined as the smallest change in a score for a patient
that indicates an actual change between two time points;
that is, the MID is the minimum change in a score that
likely reflects actual change rather than a variation in
measurement [8,9].
The HRQoL is currently weighted more heavily when
evaluating health status, particularly regarding medical
treatments and interventions. Nevertheless, it is easy to
identify the statistical significance of any such changes,
but it can be harder to determine whether these changes
are clinically or not clinically important. The MID is a
statistical value arising from the variance in measure [8].
However, it is rarely used by physicians to compare
responsiveness. Additionally, responsiveness estimates
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sion THA has not been clinically compared.
In this prospective cohort study, two well-known
HRQoL instruments, the SF-36 and the HHS, were used
to compare responsiveness and MID in revision THA
patients.
Methods
Patients and data collection
T w oH R Q o Li n s t r u m e n t sw e r eu s e dt os u r v e ya l l
patients who underwent revision THA performed by
either of two experienced surgeons practicing at two
academic hospitals in southern Taiwan between Octo-
ber, 2007 and December, 2008. Eight procedures per-
formed by other low-volume surgeons who had
performed less than three procedures annually were
excluded from analysis. Patients with cognitive impair-
ment, severe organ or psychiatric diseases (n = 5) were
excluded. Of the seventy-two eligible subjects who
gave written consent and were enrolled in the study at
baseline, five were excluded because they did not
undergo postoperative assessments. Sixty-seven
patients who completed preoperative and 6-month sur-
veys after revision THA were enrolled in the study.
Immediately before surgery, the two operating sur-
geons administered the HHS and a trained research
assistant administered the SF-36 Health Survey. The
same orthopaedists and research assistant continued
to use these instruments to assess HRQoL in the
6-month survey.
Outcome measures
The two HRQoL survey instruments in this study were
the generic Chinese version of the SF-36 and the Harris
Hip Score. The SF-36 Health Survey, a widely used mea-
sure of generic HRQoL, includes thirty-six items for
evaluating physical functioning, role limitations due to
physical problems, bodily pain, general health, vitality,
social functioning, role limitations due to emotional pro-
blems and mental health. Each SF-36 subscale was con-
verted to a scale from 0 to 100; the higher score, the
better the HRQoL. A translated version of the SF-36 has
been validated in Chinese populations [10].
The HHS ranges from 1 to 100 points, and its
domains include pain function (1 item), physical func-
tion (7 items), deformity (5 items), and range of motion
(5 items) [5]. Pain and physical functions are the two
basic considerations and are weighted most heavily in
the HHS calculation (44 and 46 points, respectively).
Physical functions are classified as daily life activities
(3 items, 13 points) and gait (4 items, 33 points). Defor-
mity and range of motion are seldom of primary impor-
tance and thus each received 5 points. The higher the
score, the better the HRQoL implies.
Statistical Analysis
The unit of analysis was the individual patient. To com-
pare SF-36 and HHS subscales, raw scores were trans-
formed and scaled from 0 to 100, with higher scores
correlating with improved HRQoL.
The generalized estimating equation (GEE) approach
is similar to that of repeated measure ANOVA but is
more powerful because it can accommodate incomplete
data for individual subjects at one or more assessment
points without compromising the remaining data for the
subject. This approach is also advocated for analyzing
incomplete data in longitudinal studies with continuous
outcomes [11,26] J. Twisk, Applied longitudinal data
analysis for epidemiology, Cambridge University Press,
Cambridge (2003). The GEE approach was employed to
compare longitudinal changes in SF-36 and HHS sub-
scales before and six months after revision THA. Each
HRQoL subscale was used as a dependent variable as a
function of time and covariates: age, gender, number of
comorbidities, average length of stay and re-hospitaliza-
tion in 30 days. Variables were entered into the GEE
analysis as covariates because they were statistically sig-
nificant in the univariate analysis and have proven to be
consistent predictors of HRQoL in many previous stu-
dies [3-5].
Responsiveness estimates were evaluated in terms of
percentage of change (PC), effect size (ES) [6-8], stan-
dardized response mean (SRM) [6-8] and relative effi-
ciency (RE) [12]. The PC was presented as the mean
change scores divided by the baseline scores. The ES
was calculated by dividing mean change score by the
standard deviation of baseline scores. The SRM was cal-
culated as the mean change score divided by the stan-
dard deviation of changed scores. Relative efficiency
(RE) is defined as the ratio of the square of the t-statis-
tic of the comparator instrument (here, each SF-36 sub-
scale score) over the square of the t-statistic of the
reference instrument (here, HHS total score). An RE
score of 1.0 indicates that the SF-36 is as efficient as the
HHS in detecting differences in external indicators of
health status. If RE exceeds 1.0, the SF-36 is more effi-
cient than the HHS at detecting differences in external
indicators of health status. If RE is lower than 1.0, the
SF-36 is less efficient than the HHS. It has been sug-
gested that a one-half standard deviation (SD) change of
the mean difference in scores may approximate an MID
for some patient-reported outcome instruments, and
that evidence from previous studies, physiologic argu-
ments, and statistical theory shows a tendency to con-
verge to the one-half-SD criteria as being meaningful to
patients [8,13]. An MCID value was determined by mul-
tiplying the SD of the mean difference in scores by 0.5.
Repeated assessment of a single patient can cause
complications due to highly correlated observations
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bias-corrected and accelerated bootstrap method with
2,000 replications and the modified Jacknife test were
used to compare responsiveness estimates between two
HRQoL instruments [9,14]. Bootstrapping is a technique
for re-sampling numerous random samples drawn from
the original sample with replacement [14]. Within each
of these samples, calculating the parameter of interest
yields an empirical sampling distribution of the estima-
tor of interest from which, without parametric assump-
tions, probability statements and confidence intervals
can be derived. Differences in ES and SRM between the
HHS and the SF-36 were estimated, and the bootstrap-
ping method was used to obtain 95% confidence inter-
vals for these differences. The modified Jacknife method
is a linear regression between the difference in ES or
SRM between two comparable scores (e.g., between SF-
36 bodily pain and HHS pain function) as the dependent
variable and the centered ES/SRM of one of the two
scales (either scale is appropriate) as the independent
variable [9]. A regression intercept (value of the SRM/
ES difference at which the centered ES/SRM equals
zero) larger or smaller than zero with significance p <
0.05 indicates that the two scales significantly differ in
responsiveness.
All statistical analyses were performed using Stata Sta-
tistical Package, Version 9.0 (Stata Corp, College Station,
TX). A p value < 0.05 was considered statistically
significant.
Results
The study sample included twenty-nine (43%) female
and thirty-eight (57%) males with a mean age of 70.2
years (standard deviation, 13.1 years; range, 50-92 years).
Preoperatively, each patient exhibited an average of 0.6
co-morbidities, and the average length of stay was 6.4
days (standard deviation, 1.7 days). The subjects who
remained in the study and those who were lost to fol-
low-up did not significantly differ in baseline age, gen-
der, number of co-morbidities, 30-day re-hospitalization,
SF-36 subscale scores, or HHS subscale scores. There-
fore, subjects with incomplete information during the
study period were assumed to have no significant con-
founding effects on the statistical results (data not
shown). The sample size in this study was sufficient to
d e t e c tat e n - p o i n td i f f e r e n c eo v e rt i m ei na l lS F - 3 6a n d
HHS subscales, assuming an a of 0.05, a power of 80%,
an inter-temporal, between-score correlation of 0.70 and
standard deviation of 10 [4,10]. This study was approved
by the Institutional Review Board of Kaohsiung Medical
University Hospital and Kaohsiung Veterans General
Hospital in Taiwan.
Longitudinal changes in all SF-36 and HHS subscales
revealed statistically significant improvement (P < 0.05)
after adjustment for baseline age, gender, education,
number of co-morbidities, operation time, average
lengths of stay and re-hospitalization in 30 days (Table
1). The SF-36 and the HHS before and 6 months after
revision THA revealed improvement rates of from
12.7% to 52.8% and from 100.0% to 180.0%, respectively.
Further, the GEE approach produced the highest mean
scores for HHS deformity and range of motion subscales
6 months after revision THA. Specifically, as compared
to a relatively low score of 29.6 before revision THA,
the mean SF-36 score for role limitations due to physi-
cal problems was 41.3 after revision THA, an improve-
ment of 39.8%. The mean SF-36 score for role
limitations due to emotional problems changed from
59.0 to 90.2, indicating the role limitations due to emo-
tional problems was the most improved subscale, with
an improvement rate of 52.8%. The least improved
SF-36 subscale was physical functioning and bodily
pain, with an improvement rate of 12.7% and 12.5%,
respectively.
The MID in the HHS pain function, physical function,
deformity, and total scores (range from 2.28 to 11.26)
are generally higher than those of the SF-36 subscales
(range from 12.37 to 22.81), except physical functioning
and role limitations due to physical problems, during
the study period (Table 1). Therefore, the correlation
between the HHS and the SF-36 required use of the
bootstrap and the modified Jacknife methods to analyze
differences in responsiveness.
Because the HHS subscale deformity and range of
motion cannot be compared with any SF-36 subscale,
we choose physical function and pain function for
responsiveness differences comparison (Table 2). The
difference may be considered statistically significant at
the 0.05 significance level if the confidence interval
excludes zero. The HHS revealed significant increases in
the ES and SRM of physical function and pain function
between the preoperative and 6-month surveys [ES of
difference in physical function 6.27 (95% CI: 5.84 to
6.69) and SRM of difference in physical function 10.42
(95% CI: 9.92 to 10.92); ES of difference in pain function
5.50 (95% CI: 5.05 to 5.95) and SRM of difference in
pain function 8.61 (95% CI: 8.21 to 9.00)]. Overall, the
HHS was statistically more responsive than the SF-36
was in terms of physical function and pain function
measurements (p < 0.001).
Discussion
Based on the assessments of the HHS and the SF-36,
this comparative study yielded systematic and compre-
hensive data regarding responsiveness and MID in
patients undergoing revision THA.
Analysis of longitudinal changes indicated the role
limitations due to physical and emotional problems of
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Before surgery, the mean scores for physical and emo-
tional roles were relatively lower than those for any
other scale, probably because these roles were limited by
the physical and emotional function of patients. The
patients could resume their role limitations immediately
after revision THA. Consequently, improved role limita-
tions might improve vitality, social functions, general
health, mental health and as well as overall quality of
life. However, the areas of pain relief and physical func-
tion revealed relatively poorer improvement than other
functions. This might implicate there was a trend for
patients who had had more severe functional problems
before the surgery to have poorer pain and physical
functions after revision THA [15]. Nevertheless, the
items for the role subscales have 5 possible answer
levels in version 2 of the SF-36 instead of 2 (present/
absent) in version 1. The role subscales are measured
more fine graded and more differentiated. The range of
possible scores has increased and differences (baseline
to follow-up) can be measured more precisely by version
2 [16].
This study is the first to compare the HHS and the
SF-36 for responsiveness and MID in revision THA
patients treated at two medical centers. The data derived
by this study can help clinicians and health researchers
decide which measure is most effective for evaluating
HRQoL before and after revision THA. The responsive-
ness estimates for the HHS generally exceeded 0.5,
which can be interpreted as medium change [17,18].
Partial subscales of the SF-36 also presented good
results in responsiveness estimates and MID, which
revealed improvement after surgery. This study also
revealed the close algebraic relationship and conceptual
differences between ES and SRM estimates, which is
consistent with an earlier report by Zou [19].
Schmitt and Fabio [20] contrasted the use of respon-
siveness indicators at the group level versus the indivi-
dual patient level. While several other studies in
orthopedic surgery and medicine have used MID to
Table 1 Estimated responsiveness and minimal important differences (MID) for the SF-36 and the Harris Hip Score
(HHS)
§
Indicators of responsiveness MID
Subscale Mean (S.D.) Mean (S.D.) Mean (S.D.) P value PC (%) ES SRM RE
SF-36
PF 64.1(6.7) 72.2(6.4) 8.1(6.5) <0.001 12.67 1.22 1.25 0.07 3.25
RP 29.6(14.3) 41.3(7.2) 11.8(9.6) <0.001 39.77 0.82 1.23 0.10 4.78
RE 59.0(36.2) 90.2(43.7) 31.2(40.0) <0.001 52.80 0.86 0.78 0.33 19.98
SF 69.8(45.9) 88.2(47.2) 18.4(31.7) <0.001 26.30 0.40 0.58 0.21 15.83
BP 73.7(22.5) 82.9(24.5) 9.2(29.8) <0.001 12.54 0.41 0.31 0.09 14.91
VT 53.4(34.0) 76.2(36.0) 22.8(45.6) <0.001 42.71 0.67 0.50 0.21 22.81
MH 69.4(21.4) 82.2(22.3) 12.9(24.7) <0.001 18.54 0.60 0.52 0.11 12.37
GH 64.1(42.3) 78.5(48.2) 14.4(28.2) <0.001 22.46 0.34 0.51 0.12 14.12
HHS
Pain 34.1(10.4) 95.4(15.7) 61.4(6.9) <0.001 179.99 5.91 8.92 0.57 3.44
Function 35.9(7.1) 89.1(9.4) 53.3(4.6) <0.001 148.48 7.49 11.67 0.49 2.28
Deformity 50.0(11.7) 100.0(20.0) 50.0(22.5) <0.001 100.00 4.28 2.22 0.67 11.26
Motion 50.0(10.1) 100.0(14.7) 50.0(35.7) <0.001 100.00 4.95 1.40 0.72 17.86
Total scores 36.5(6.6) 93.0(17.8) 56.5(4.9) <0.001 154.79 8.57 11.58 1.00 2.44
§PC = percentage of change; ES = effect size; SRM = standard responsiveness means; RE = relative efficiency; CL = 95% confidence interval at lower limit; CU =
95% confidence interval at upper limit; PF = physical functioning; RP = role limitations due to physical problems; RE = role limitations due to emotional
problems; SF = social functioning; BP = bodily pain; VT = vitality; MH = mental health; GH = general health; Pain = pain function; Function = physical function;
Deformity = deformity; Motion = range of motion.
Table 2 Comparative responsiveness estimates of effect size (ES) and standardized response mean (SRM) of the SF-36
and the Harris Hip Score (HHS)
HHS - SF-36
ES (Estimate [95% CI])
§ SRM (Estimate [95% CI])
§ p(ES)* p(SRM)*
Physical function 6.27 (5.84, 6.69) 10.42 (9.92, 10.92) <0.001 <0.001
Pain function 5.50 (5.05, 5.95) 8.61 (8.21, 9.00) <0.001 <0.001
§Differences are presented in effect size and standardized response means (95% confidence interval obtained by bootstrapping).
*p: Type I error of the modified Jacknife test comparing two ES or two SRM.
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have applied MID calculations to the HHS.
Importantly, although the improvements were in dif-
ferent subscales of the HHS and the SF-36, the esti-
mated responsiveness of the HHS generally was greater
than that of the SF-36. However, such the responsive-
ness estimates in previous studies [3,15] were made
using a small sample size or lacked comparative statisti-
cal data before and after interventions. Thus, the boot-
strap method employed in this study generated a 95%
confidence interval. Although the two measures signifi-
cantly differed in responsiveness, each exhibited superior
responsiveness in different subscales. The HHS exhib-
ited superior responsiveness in physical function and
pain function subscales.
An acknowledged limitation of this study is the small
sample size, which restricts the extent to which the
findings can be generalized to larger populations. Future
studies are needed to examine outcomes, patient attri-
butes, hospital attributes, care quality, preoperative func-
tional status and related factors in a larger population.
Further, the patient outcome may be highly dependent
on variables such as operator proficiency, advancing
technology and available facilities [21]. However, all pro-
cedures evaluated in this study were performed by sur-
geons with the most experience in revision THA
procedures in each of two different institutions, and the
potential confounding factors in both responsiveness
and MID were controlled simultaneously. Given this
design, the surgical outcomes in this study were more
representative than those of a single-surgeon study.
To confirm the data regarding the responsiveness and
MID of the HHS and the SF-36 scores, Table 3 presents
an international data comparison. The findings of this
Table 3 Comparative responsiveness and minimal important differences (MID) of health-related quality of life (HRQoL)
instruments reported in previous studies
Authors Country No. of subjects Measurement
time intervals
Instrument* Findings
Shi HY, et al.
(present study)
Taiwan 67 revision THA Preoperative
and 6-month
surveys
HHS, SF-36 HHS revealed greater overall responsiveness than
the SF-36 between pre-op and 6-month surveys.
Soohoo NF, et
al. (2007)[7]
U.S. 89 primary THA Preoperative
and 5 to 17-
month surveys
WOMAC, SF-36 The standardized response means (SRM) for the
WOMAC ranged from -0.93 to -1.49, and the effect
size (ES) ranged from -1.02 to -1.53. The SRM for
the SF-36 ranged from 0.22 to 1.64, and the ES
ranged from 0.20 to 1.97.
Quintana JM,
et al. (2005)
[22]
Spain 310 primary THA Preoperative, 6-
and 24-month
surveys
WOMAC, SF-36 WOMAC exhibited treatment responsiveness
superior to the SF-36. The percentage of minimal
detectable change (MDC) was higher than 80% for
all WOMAC domains, except stiffness (60%), while
it was higher than 40% in the physical domains of
the SF-36 (physical function, physical role, or
bodily pain).
Angst F,
et al. (2001)
[23]
Switzerland 433 hip or knee OA Preoperative
and 3-month
surveys
WOMAC, SF-36 SRM = 0.723 for WOMAC and SRM = 0.528 for SF-
36 at the end of rehabilitation; SRM = 0.377 for
WOMAC and SRM = 0.468 for SF-36 at the three
month follow up. In the measurement of function,
the WOMAC was significantly more responsive
than the SF-36 (SRMs, end of rehabilitation: 0.628
vs. 0.249; three month follow up: 0.235 vs. -0.001).
Hoeksma HL,
et al. (2003)
[24]
Netherlands 75 hip OA Preoperative
and 5-week
surveys
HHS, SF-36 The responsiveness ratio for the HHS was high
(1.70) compared with walking speed (0.45), pain
during walking (0.66), and the subscales of the SF-
36-"bodily pain” (0.42) and “physical functioning”
(0.36).
Weigl M, et al.
(2006)[25]
Germany 439 low (upper) back pain
and conditions of the lower
(upper) extremities patients
Preoperative
and 2~4-week
surveys
SCQ SF-36 NASS
DASH
The condition-specific instruments demonstrated a
good responsiveness with an ES ranging between
0.28 and 0.55 and with a SRM between 0.32 and
0.94. The responsiveness of the SF-36 Physical
Function scale showed a lower responsiveness
than the condition-specific scales.
Lübbeke A, et
al. (2007) [26]
Switzerland 435 primary THA, 116
revision THA
Preoperative
and 5-year
surveys
HHS, WOMAC,
SF-12
HHS and WOMAC were relatively more responsive
for physical and pain functions than the SF-12.
*HHS = Harris Hip Score, SF-36 = Medical Outcomes Study Short Form-36 Health Survey, WOMAC = Western Ontario and McMaster Universities Osteoarthritis
Index, SCQ = Self-administered Comorbidity Questionnaire, NASS = North American Spine Society Questionnaire, DASH = Disabilities of Arm, Shoulder, and Hand
Questionnaire
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ted States and European populations [7,22-26]. These
studies were selected because they were similar to the
current study in terms of sample size, mean age of the
population, measurement time points (including pre-
operation and at least 6 months postoperative), and,
most importantly, the use of both disease-specific and
generic measures. The current finding of greater respon-
siveness of the disease-specific measure in comparison
with the generic measure was consistent with all com-
parable studies examined. Specifically, the increased
responsiveness of the disease-specific measure suggests
that physical and related functions improve more rapidly
and more completely than overall quality of life in
patients who undergo revision THA.
Conclusion
The comparative results of this prospective observa-
tional study provide comprehensive and systematic
information regarding the expected responsiveness and
MID in patients undergoing revision THA. The HHS
exhibited responsiveness superior to that of the SF-36
between the preoperative and 6-month surveys. There-
fore, clinicians and health researchers may consider
weighting the HHS more heavily than the SF-36 to
determine treatment effectiveness. Further study may
also examine the extent to which the HRQoL instru-
ment is applicable to other forms of orthopaedic
surgery.
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